Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin-Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03671850
What this trial is testing

VT-EBV-N for Treatment of Severe in EBV Positive Extranodal NK/T Cell Lymphoma Patients

Who this might be right for
Extranodal NK/T-cell Lymphoma
ViGenCell Inc. 48
Not applicableLooking for participantsNCT06739759
What this trial is testing

Ovarian Hyperstimulation Syndrome Prevention

Who this might be right for
Ovarian Hyper Stimulation Syndrome (OHSS)
Aljazeera Hospital 300
Early research (Phase 1)UnknownNCT01619761
What this trial is testing

NK Cells in Cord Blood Transplantation

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in Remission+22 more
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT00004061
What this trial is testing

Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer

Who this might be right for
LeukemiaLymphomaOral Complications
Memorial Sloan Kettering Cancer Center 111
Testing effectiveness (Phase 2)UnknownNCT05008666
What this trial is testing

Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH

Who this might be right for
Safety and Efficacy
Sun Yat-sen University 37
Early research (Phase 1)Not Yet RecruitingNCT06385522
What this trial is testing

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

Who this might be right for
NHLCutaneous T Cell LymphomaPeripheral T-cell Lymphoma
Boston Immune Technologies and Therapeutics 37
Testing effectiveness (Phase 2)Study completedNCT01018979
What this trial is testing

Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaHodgkin Disease
GPCR Therapeutics, Inc. 19
Early research (Phase 1)Study completedNCT00562380
What this trial is testing

AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma

Who this might be right for
LymphomaProstate CancerSarcoma+2 more
Amgen 64
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT07525466
What this trial is testing

Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)

Who this might be right for
Extranodal NK T Cell LymphomaHemophagocytic Lymphohistiocytosis (HLH)
Beijing Tongren Hospital 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04718883
What this trial is testing

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd. 59
Testing effectiveness (Phase 2)UnknownNCT05955105
What this trial is testing

ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Who this might be right for
Head and Neck CancerCervical CancerEndometrial Cancer+7 more
Innolake Biopharm 200
Testing effectiveness (Phase 2)Ended earlyNCT05537766
What this trial is testing

Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies

Who this might be right for
Relapsed/Refractory Waldenstrom MacroglobulinemiaRelapsed/Refractory Richter TransformationRelapsed/Refractory Burkitt Lymphoma+1 more
Kite, A Gilead Company 19
Early research (Phase 1)Study completedNCT00418366
What this trial is testing

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

Who this might be right for
Renal InsufficiencyHemodialysis
Merck Sharp & Dohme LLC 24
Early research (Phase 1)Active Not RecruitingNCT06192888
What this trial is testing

Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma

Who this might be right for
Mantle Cell LymphomaMCL
Memorial Sloan Kettering Cancer Center 39
Testing effectiveness (Phase 2)Study completedNCT00163761
What this trial is testing

Efficacy Study of Outpatient Therapy for Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's Disease
Bayside Health 90
Testing effectiveness (Phase 2)Looking for participantsNCT05296070
What this trial is testing

Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma

Who this might be right for
Marginal Zone Lymphoma
University of Miami 50
Testing effectiveness (Phase 2)Ended earlyNCT00322296
What this trial is testing

Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis

Who this might be right for
Parapsoriasis
Fox Chase Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT00428142
What this trial is testing

Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
NCIC Clinical Trials Group 95
Large-scale testing (Phase 3)WithdrawnNCT01355783
What this trial is testing

Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-Cell Lymphoma
Eisai Inc.
Next Page